<DOC>
	<DOCNO>NCT00679601</DOCNO>
	<brief_summary>The purpose study determine absorption systemic pharmacokinetics AN2690 follow daily application ten ( 10 ) toenail 28 day .</brief_summary>
	<brief_title>Absorption Systemic Study AN2690 Patients With Moderate Severe Onychomycosis ( ADME II )</brief_title>
	<detailed_description>A single center , open-label , multiple-dose study design use . Planned enrollment 20 subject complete 15 . Subjects must clinical diagnosis onychomycosis great toenail clinical diagnosis onychomycosis six remain toenail .</detailed_description>
	<mesh_term>Onychomycosis</mesh_term>
	<mesh_term>Tavaborole</mesh_term>
	<criteria>Male female ≥18 ≤65 BMI 18.5 35 inclusive Moderate severe onychomycosis involve ≥80 % great toenail , determine visual inspection nail trim Combined thickness nail plate nail bed great toenail &gt; 3mm At least 6 additional toenail clinical diagnosis onychomycosis If female childbearing potential , must use highly effective method birth control abstinence willing remain method birth control throughout study Capable understand signing informed consent , willing comply requirement study History allergy study drug component test product ( ) history hypersensitivity allergic reaction study preparation describe Investigator 's Brochure Clinically significant laboratory abnormality would interfere conduct interpretation study jeopardize his/her safety Diabetes mellitus require treatment diet exercise Willing refrain use nail cosmetic clear color nail lacquer screen visit end study Nursing , pregnant planning become pregnant study Failure complete specify washout period ( ) follow topical : 1 . Topical antifungal apply foot ( include antifungal treatment T. pedis study ) : 4 week 2 . Antiinflammatories , corticosteroid , topical immunomodulators : 2 week Failure complete specify washout period ( ) follow systemic medication : 1 . Corticosteroids ( include intramuscular injection ) : 2 week 2 . Antifungals treatment onychomycosis systemic antifungal know activity dermatophyte : 24 week 3 . Systemic immunomodulators : 4 week Received treatment type cancer within last 6 month History significant internal disease Nail anatomic abnormality toe , e.g. , genetic nail disorder , primentary disorder , onychogryphosis , trauma nail ( ) treat AIDS AIDS relate complex History street drug alcohol abuse Donated lose blood , participate clinical study involve withdrawal large volume blood ( 480 mL ) , sixweek period precede study initiation Donated plasma two week period precede study initiation Participated trial investigational drug device within 30 day prior enrollment participation research study concurrent study Prior enrollment study use study drug , AN2690</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>May 2008</verification_date>
	<keyword>Onychomycosis</keyword>
	<keyword>Fungal Nail</keyword>
</DOC>